Selected research
Industry Research
Terbinafine Hydrochloride Drug Industry Research Report 2026
Market perspective
The global Terbinafine Hydrochloride Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Terbinafine Hydrochloride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Terbinafine Hydrochloride Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Terbinafine Hydrochloride Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Terbinafine Hydrochloride Drug include APOTEX, Breckenridge Pharmaceutical, CIPLA LTD, Cussess, Dr. Reddy's Laboratories, Glenmark, Harris Pharmaceutical, InvaGen Pharmaceuticals and Orchid Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Terbinafine Hydrochloride Drug market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Terbinafine Hydrochloride Drug Market by Company
APOTEX
Breckenridge Pharmaceutical
CIPLA LTD
Cussess
Dr. Reddy's Laboratories
Glenmark
Harris Pharmaceutical
InvaGen Pharmaceuticals
Orchid Healthcare
TARO
GSK
Hubei Hengan Fulin Pharm
Jilin Wantong Group
Novartis
TEVA
Xiuzheng Pharmaceutical
Terbinafine Hydrochloride Drug Segment by Type
Topical
Oral
Terbinafine Hydrochloride Drug Segment by Application
Fingernail Infection
Toenail Infection
Others
Terbinafine Hydrochloride Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Terbinafine Hydrochloride Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Terbinafine Hydrochloride Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Terbinafine Hydrochloride Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Terbinafine Hydrochloride Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Terbinafine Hydrochloride Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Terbinafine Hydrochloride Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Topical
- Oral
Applications
- Fingernail Infection
- Toenail Infection
- Others
Companies covered
- APOTEX
- Breckenridge Pharmaceutical
- CIPLA LTD
- Cussess
- Dr. Reddy's Laboratories
- Glenmark
- Harris Pharmaceutical
- InvaGen Pharmaceuticals
- Orchid Healthcare
- TARO
- GSK
- Hubei Hengan Fulin Pharm
- Jilin Wantong Group
- Novartis
- TEVA
- Xiuzheng Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Terbinafine Hydrochloride Drug Market Size (2021-2032)
- 2.2.2 Global Terbinafine Hydrochloride Drug Sales (2021-2032)
- 2.2.3 Global Terbinafine Hydrochloride Drug Market Average Price (2021-2032)
- 2.3 Terbinafine Hydrochloride Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Topical
- 2.3.3 Oral
- 2.4 Terbinafine Hydrochloride Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Fingernail Infection
- 2.4.3 Toenail Infection
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Terbinafine Hydrochloride Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Terbinafine Hydrochloride Drug Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Terbinafine Hydrochloride Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Terbinafine Hydrochloride Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Terbinafine Hydrochloride Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Terbinafine Hydrochloride Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Terbinafine Hydrochloride Drug, Product Type & Application
- 3.8 Global Manufacturers of Terbinafine Hydrochloride Drug, Established Date
- 3.9 Global Terbinafine Hydrochloride Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 APOTEX
- 4.1.1 APOTEX Company Information
- 4.1.2 APOTEX Business Overview
- 4.1.3 APOTEX Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 APOTEX Terbinafine Hydrochloride Drug Product Portfolio
- 4.1.5 APOTEX Recent Developments
- 4.2 Breckenridge Pharmaceutical
- 4.2.1 Breckenridge Pharmaceutical Company Information
- 4.2.2 Breckenridge Pharmaceutical Business Overview
- 4.2.3 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Breckenridge Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
- 4.2.5 Breckenridge Pharmaceutical Recent Developments
- 4.3 CIPLA LTD
- 4.3.1 CIPLA LTD Company Information
- 4.3.2 CIPLA LTD Business Overview
- 4.3.3 CIPLA LTD Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CIPLA LTD Terbinafine Hydrochloride Drug Product Portfolio
- 4.3.5 CIPLA LTD Recent Developments
- 4.4 Cussess
- 4.4.1 Cussess Company Information
- 4.4.2 Cussess Business Overview
- 4.4.3 Cussess Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cussess Terbinafine Hydrochloride Drug Product Portfolio
- 4.4.5 Cussess Recent Developments
- 4.5 Dr. Reddy's Laboratories
- 4.5.1 Dr. Reddy's Laboratories Company Information
- 4.5.2 Dr. Reddy's Laboratories Business Overview
- 4.5.3 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Dr. Reddy's Laboratories Terbinafine Hydrochloride Drug Product Portfolio
- 4.5.5 Dr. Reddy's Laboratories Recent Developments
- 4.6 Glenmark
- 4.6.1 Glenmark Company Information
- 4.6.2 Glenmark Business Overview
- 4.6.3 Glenmark Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Glenmark Terbinafine Hydrochloride Drug Product Portfolio
- 4.6.5 Glenmark Recent Developments
- 4.7 Harris Pharmaceutical
- 4.7.1 Harris Pharmaceutical Company Information
- 4.7.2 Harris Pharmaceutical Business Overview
- 4.7.3 Harris Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Harris Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
- 4.7.5 Harris Pharmaceutical Recent Developments
- 4.8 InvaGen Pharmaceuticals
- 4.8.1 InvaGen Pharmaceuticals Company Information
- 4.8.2 InvaGen Pharmaceuticals Business Overview
- 4.8.3 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 InvaGen Pharmaceuticals Terbinafine Hydrochloride Drug Product Portfolio
- 4.8.5 InvaGen Pharmaceuticals Recent Developments
- 4.9 Orchid Healthcare
- 4.9.1 Orchid Healthcare Company Information
- 4.9.2 Orchid Healthcare Business Overview
- 4.9.3 Orchid Healthcare Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Orchid Healthcare Terbinafine Hydrochloride Drug Product Portfolio
- 4.9.5 Orchid Healthcare Recent Developments
- 4.10 TARO
- 4.10.1 TARO Company Information
- 4.10.2 TARO Business Overview
- 4.10.3 TARO Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 TARO Terbinafine Hydrochloride Drug Product Portfolio
- 4.10.5 TARO Recent Developments
- 4.11 GSK
- 4.11.1 GSK Company Information
- 4.11.2 GSK Business Overview
- 4.11.3 GSK Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 GSK Terbinafine Hydrochloride Drug Product Portfolio
- 4.11.5 GSK Recent Developments
- 4.12 Hubei Hengan Fulin Pharm
- 4.12.1 Hubei Hengan Fulin Pharm Company Information
- 4.12.2 Hubei Hengan Fulin Pharm Business Overview
- 4.12.3 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hubei Hengan Fulin Pharm Terbinafine Hydrochloride Drug Product Portfolio
- 4.12.5 Hubei Hengan Fulin Pharm Recent Developments
- 4.13 Jilin Wantong Group
- 4.13.1 Jilin Wantong Group Company Information
- 4.13.2 Jilin Wantong Group Business Overview
- 4.13.3 Jilin Wantong Group Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Jilin Wantong Group Terbinafine Hydrochloride Drug Product Portfolio
- 4.13.5 Jilin Wantong Group Recent Developments
- 4.14 Novartis
- 4.14.1 Novartis Company Information
- 4.14.2 Novartis Business Overview
- 4.14.3 Novartis Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Novartis Terbinafine Hydrochloride Drug Product Portfolio
- 4.14.5 Novartis Recent Developments
- 4.15 TEVA
- 4.15.1 TEVA Company Information
- 4.15.2 TEVA Business Overview
- 4.15.3 TEVA Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 TEVA Terbinafine Hydrochloride Drug Product Portfolio
- 4.15.5 TEVA Recent Developments
- 4.16 Xiuzheng Pharmaceutical
- 4.16.1 Xiuzheng Pharmaceutical Company Information
- 4.16.2 Xiuzheng Pharmaceutical Business Overview
- 4.16.3 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Xiuzheng Pharmaceutical Terbinafine Hydrochloride Drug Product Portfolio
- 4.16.5 Xiuzheng Pharmaceutical Recent Developments
5 Global Terbinafine Hydrochloride Drug Market Scenario by Region
- 5.1 Global Terbinafine Hydrochloride Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Terbinafine Hydrochloride Drug Sales by Region: 2021-2032
- 5.2.1 Global Terbinafine Hydrochloride Drug Sales by Region: 2021-2026
- 5.2.2 Global Terbinafine Hydrochloride Drug Sales by Region: 2027-2032
- 5.3 Global Terbinafine Hydrochloride Drug Revenue by Region: 2021-2032
- 5.3.1 Global Terbinafine Hydrochloride Drug Revenue by Region: 2021-2026
- 5.3.2 Global Terbinafine Hydrochloride Drug Revenue by Region: 2027-2032
- 5.4 North America Terbinafine Hydrochloride Drug Market Facts & Figures by Country
- 5.4.1 North America Terbinafine Hydrochloride Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Terbinafine Hydrochloride Drug Sales by Country (2021-2032)
- 5.4.3 North America Terbinafine Hydrochloride Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Terbinafine Hydrochloride Drug Market Facts & Figures by Country
- 5.5.1 Europe Terbinafine Hydrochloride Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Terbinafine Hydrochloride Drug Sales by Country (2021-2032)
- 5.5.3 Europe Terbinafine Hydrochloride Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Terbinafine Hydrochloride Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Terbinafine Hydrochloride Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Terbinafine Hydrochloride Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Terbinafine Hydrochloride Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Terbinafine Hydrochloride Drug Market Facts & Figures by Country
- 5.7.1 South America Terbinafine Hydrochloride Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Terbinafine Hydrochloride Drug Sales by Country (2021-2032)
- 5.7.3 South America Terbinafine Hydrochloride Drug Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Terbinafine Hydrochloride Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Terbinafine Hydrochloride Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Terbinafine Hydrochloride Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Terbinafine Hydrochloride Drug Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Terbinafine Hydrochloride Drug Sales by Type (2021-2032)
- 6.1.1 Global Terbinafine Hydrochloride Drug Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Terbinafine Hydrochloride Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Terbinafine Hydrochloride Drug Revenue by Type (2021-2032)
- 6.2.1 Global Terbinafine Hydrochloride Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Terbinafine Hydrochloride Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Terbinafine Hydrochloride Drug Sales by Application (2021-2032)
- 7.1.1 Global Terbinafine Hydrochloride Drug Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Terbinafine Hydrochloride Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Terbinafine Hydrochloride Drug Revenue by Application (2021-2032)
- 7.2.1 Global Terbinafine Hydrochloride Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Terbinafine Hydrochloride Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Terbinafine Hydrochloride Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Terbinafine Hydrochloride Drug Value Chain Analysis
- 8.1.1 Terbinafine Hydrochloride Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Terbinafine Hydrochloride Drug Production Mode & Process
- 8.2 Terbinafine Hydrochloride Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Terbinafine Hydrochloride Drug Distributors
- 8.2.3 Terbinafine Hydrochloride Drug Customers
9 Global Terbinafine Hydrochloride Drug Analyzing Market Dynamics
- 9.1 Terbinafine Hydrochloride Drug Industry Trends
- 9.2 Terbinafine Hydrochloride Drug Industry Drivers
- 9.3 Terbinafine Hydrochloride Drug Industry Opportunities and Challenges
- 9.4 Terbinafine Hydrochloride Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst